Select committee: Women and Equalities Committee

Evidence base on the safety and effectiveness of puberty blockers

Closed Opened 11 Dec 2024 Closed 23 Jan 2026
Inquiry scope (the committee's words)
In December 2024, the Government announced it was making the ban on the sale and supply of puberty-suppressing hormones to under-18s, except for purposes other than gender incongruence and/or gender dysphoria, indefinite. It also announced it was setting up a clinical trial into the use of puberty blockers to establish a clear evidence base for their use. The Women and Equalities Committee will examine the medical evidence for an indefinite ban and how a research trial on puberty blockers should be set up in order for it to be safe and produce robust results.

Where it stands

The inquiry is closed, opened 11 December 2024.

The committee has not published a report yet.

Oral evidence sessions

1 session

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date Session and witnesses Source
22 Jan 2025
Women and Equalities Committee
Professor Ashley Grossman MD FRCP FMedSci, Professor Gary Butler MD FRCPCH, Professor Simona Giordano PhD
View ↗

Who gave evidence

3 witnesses

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

WitnessOrganisationSessions
Professor Ashley Grossman MD FRCP FMedSci Not recorded 1
Professor Gary Butler MD FRCPCH Not recorded 1
Professor Simona Giordano PhD Not recorded 1

Correspondence

2 letters

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.